S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
From -60% Account to Doubling His Money? (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Twitter executive responsible for content safety resigns after Elon Musk criticism
From -60% Account to Doubling His Money? (Ad)
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
From -60% Account to Doubling His Money? (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Twitter executive responsible for content safety resigns after Elon Musk criticism
From -60% Account to Doubling His Money? (Ad)
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
From -60% Account to Doubling His Money? (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Twitter executive responsible for content safety resigns after Elon Musk criticism
From -60% Account to Doubling His Money? (Ad)
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software" (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
From -60% Account to Doubling His Money? (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Twitter executive responsible for content safety resigns after Elon Musk criticism
From -60% Account to Doubling His Money? (Ad)
NASDAQ:TNDM

Tandem Diabetes Care (TNDM) Stock Forecast, Price & News

$24.77
+0.21 (+0.86%)
(As of 06/2/2023 ET)
Compare
Today's Range
$24.13
$25.25
50-Day Range
$24.56
$42.46
52-Week Range
$24.13
$70.81
Volume
1.42 million shs
Average Volume
1.31 million shs
Market Capitalization
$1.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$53.14

Tandem Diabetes Care MarketRank™ Forecast

Analyst Rating
Hold
2.30 Rating Score
Upside/​Downside
114.5% Upside
$53.14 Price Target
Short Interest
Bearish
9.70% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.64
Upright™ Environmental Score
News Sentiment
1.44mentions of Tandem Diabetes Care in the last 14 days
Based on 7 Articles This Week
Insider Trading
Balanced
Insiders Both Buying and Selling
Proj. Earnings Growth
Growing
From ($1.19) to ($0.66) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.32 out of 5 stars

Medical Sector

223rd out of 983 stocks

Surgical & Medical Instruments Industry

22nd out of 97 stocks


TNDM stock logo

About Tandem Diabetes Care (NASDAQ:TNDM) Stock

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

Receive TNDM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter.

TNDM Stock News Headlines

Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 3.2%
Free SMS Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Free SMS Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
8 Analysts Have This to Say About Tandem Diabetes Care
See More Headlines

TNDM Price History

TNDM Company Calendar

Last Earnings
2/22/2023
Today
6/03/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TNDM
Fax
N/A
Employees
2,600
Year Founded
2006

Price Target and Rating

Average Stock Price Forecast
$53.14
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+114.5%
Consensus Rating
Hold
Rating Score (0-4)
2.30
Research Coverage
10 Analysts

Profitability

Net Income
$-94,590,000.00
Pretax Margin
-25.17%

Debt

Sales & Book Value

Annual Sales
$801.22 million
Book Value
$5.24 per share

Miscellaneous

Free Float
63,006,000
Market Cap
$1.60 billion
Optionable
Optionable
Beta
0.93

Social Links


Key Executives

  • John F. SheridanJohn F. Sheridan
    President, Chief Executive Officer & Director
  • David B. Berger
    Chief Operating Officer, EVP & Assistant Secretary
  • Leigh A. VossellerLeigh A. Vosseller
    CFO, Treasurer, Principal Accounting Officer & EVP
  • Michael Michaud
    Vice President-Research & Development
  • Peter Rossiter
    Vice President-Information Technology













TNDM Stock - Frequently Asked Questions

Should I buy or sell Tandem Diabetes Care stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tandem Diabetes Care in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TNDM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TNDM, but not buy additional shares or sell existing shares.
View TNDM analyst ratings
or view top-rated stocks.

What is Tandem Diabetes Care's stock price forecast for 2023?

10 analysts have issued 12 month price targets for Tandem Diabetes Care's stock. Their TNDM share price forecasts range from $33.00 to $75.00. On average, they expect the company's share price to reach $53.14 in the next twelve months. This suggests a possible upside of 114.5% from the stock's current price.
View analysts price targets for TNDM
or view top-rated stocks among Wall Street analysts.

How have TNDM shares performed in 2023?

Tandem Diabetes Care's stock was trading at $44.95 at the beginning of 2023. Since then, TNDM stock has decreased by 44.9% and is now trading at $24.77.
View the best growth stocks for 2023 here
.

When is Tandem Diabetes Care's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our TNDM earnings forecast
.

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) announced its earnings results on Wednesday, February, 22nd. The medical device company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.01. The medical device company had revenue of $223.45 million for the quarter, compared to the consensus estimate of $221.99 million. Tandem Diabetes Care had a negative trailing twelve-month return on equity of 17.77% and a negative net margin of 25.64%. The company's revenue was up 6.4% compared to the same quarter last year. During the same period last year, the firm earned $0.16 earnings per share.

When did Tandem Diabetes Care's stock split?

Shares of Tandem Diabetes Care reverse split on the morning of Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What guidance has Tandem Diabetes Care issued on next quarter's earnings?

Tandem Diabetes Care updated its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $885.00 million-$900.00 million, compared to the consensus revenue estimate of $890.00 million.

What is John Sheridan's approval rating as Tandem Diabetes Care's CEO?

11 employees have rated Tandem Diabetes Care Chief Executive Officer John Sheridan on Glassdoor.com. John Sheridan has an approval rating of 88% among the company's employees.

What other stocks do shareholders of Tandem Diabetes Care own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tandem Diabetes Care investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Micron Technology (MU), DexCom (DXCM), Netflix (NFLX), Block (SQ), Roku (ROKU), Lululemon Athletica (LULU) and PayPal (PYPL).

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

Who are Tandem Diabetes Care's major shareholders?

Tandem Diabetes Care's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.25%), FMR LLC (12.75%), Champlain Investment Partners LLC (5.07%), Brown Capital Management LLC (3.36%), State Street Corp (3.20%) and Stephens Investment Management Group LLC (1.59%). Insiders that own company stock include Brian B Hansen, Brian B Hansen, Christopher J Twomey, Christopher J Twomey, David B Berger, Dick Allen, Elizabeth Anne Gasser, James Leal, John F Sheridan, Kathleen Mcgroddy-Goetz, Kim D Blickenstaff, Leigh Vosseller, Mark Reinstra, Rebecca B Robertson, Rebecca B Robertson and Susan Morrison.
View institutional ownership trends
.

How do I buy shares of Tandem Diabetes Care?

Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tandem Diabetes Care's stock price today?

One share of TNDM stock can currently be purchased for approximately $24.77.

How much money does Tandem Diabetes Care make?

Tandem Diabetes Care (NASDAQ:TNDM) has a market capitalization of $1.60 billion and generates $801.22 million in revenue each year. The medical device company earns $-94,590,000.00 in net income (profit) each year or ($3.17) on an earnings per share basis.

How many employees does Tandem Diabetes Care have?

The company employs 2,600 workers across the globe.

How can I contact Tandem Diabetes Care?

Tandem Diabetes Care's mailing address is 11075 ROSELLE STREET, San Diego CA, 92121. The official website for the company is www.tandemdiabetes.com. The medical device company can be reached via phone at (858) 366-6900 or via email at smorrison@tandemdiabetes.com.

This page (NASDAQ:TNDM) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -